Cappello, Giovanni
Cresti, Laura
Cortese, Clelia
Bocchi, Letizia
Bianchini, Elena
Carlucci, Filippo
Fiorini, Marcello
Brunetti, Jlenia
Falciani, Chiara
Bracci, Luisa
Pini, Alessandro https://orcid.org/0000-0002-3832-8349
Article History
Received: 2 September 2024
Accepted: 3 October 2025
First Online: 27 October 2025
Competing-interests
: The authors declare the following competing interests: the peptide SET-M33 is covered by patents owned by SetLance srl or by the University of Siena and licensed to SetLance srl. A.P., C.F., and L.B. are partners of SetLance. The rest of the authors declare that they have no other competing interests.